An interactive discussion of sponsor/CRO collaboration, clinical trial technology, and operational process improvement.

Moderated by: Mark Uehling, Founder and Editor of ClinPage
Panelists include: Barry Templin, Associate Director of Clinical Programs, Abbott Vascular; Ken Getz, Senior Research Fellow, Tufts Center for the Study of Drug Development; Denise Calaprice-Whitty, Ph.D., Executive Director, The Avoca Group; and Mike Soenen, CEO, ClearTrial
Original Air Date: December 16, 2010

+1 312 460 3000 | info@cleartrial.com | www.cleartrial.com